Effects of hydropeaking on drift, stranding and community composition of macroinvertebrates : a field experimental approach in three regulated Swiss rivers

Hydropeaking operation leads to fluctuations in wetted area between base and peak flow and increases discharge-related hydraulic forces (e.g. flow velocity). These processes promote macroinvertebrate drift and stranding, often affecting benthic abundance and biomass. Our field experimental study—conducted in three hydropeakingregulated Swiss rivers—aimed to quantify (a) the short-term effects of the combined increase in flow amplitude and up-ramping rate based on macroinvertebrate drift and stranding, as well as (b) long-term effects based on the established community composition. Hydropeaking led to increased macroinvertebrate drift compared to base flow and to unaffected residual flow reaches. Moreover, stranding of macroinvertebrates was positively related to drift, especially during the up-ramping phase. Flow velocity and up-ramping rate were identified as major determinants for macroinvertebrate drift, while flow ratio and down-ramping rate for stranding. Particularly high sensitivity towards hydropeaking was found for Limnephilidae, whereas Heptageniidae seemed to be resistant in respect to short- and long-term hydropeaking effects. In the longterm, hydropeaking did not considerably reduce benthic density of most taxa, especially of some highly resistant and resilient taxa such as Chironomidae and Baetidae, which dominated the community composition even though they showed comparably high drift and stranding responses. Therefore, we argue that high drift and/or stranding, especially of individual-rich taxa, does not necessarily indicate strong hydropeaking sensitivity. Finally, our results demonstrate the necessity to consider the differences in river-specific morphological complexity and hydropeaking intensity, since these factors strongly influence the community composition and short-term drift and stranding response of macroinvertebrates to hydropower pressure

Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers

Metabolomic profiling and the integration of whole-genome genetic association data has proven to be a powerful tool to comprehensively explore gene regulatory networks and to investigate the effects of genetic variation at the molecular level. Serum metabolite concentrations allow a direct readout of biological processes, and association of specific metabolomic signatures with complex diseases such as Alzheimer's disease and cardiovascular and metabolic disorders has been shown. There are well-known correlations between sex and the incidence, prevalence, age of onset, symptoms, and severity of a disease, as well as the reaction to drugs. However, most of the studies published so far did not consider the role of sexual dimorphism and did not analyse their data stratified by gender. This study investigated sex-specific differences of serum metabolite concentrations and their underlying genetic determination. For discovery and replication we used more than 3,300 independent individuals from KORA F3 and F4 with metabolite measurements of 131 metabolites, including amino acids, phosphatidylcholines, sphingomyelins, acylcarnitines, and C6-sugars. A linear regression approach revealed significant concentration differences between males and females for 102 out of 131 metabolites (p-values<3.8 x 10(-4); Bonferroni-corrected threshold). Sex-specific genome-wide association studies (GWAS) showed genome-wide significant differences in beta-estimates for SNPs in the CPS1 locus (carbamoyl-phosphate synthase 1, significance level: p<3.8 x 10(-10); Bonferroni-corrected threshold) for glycine. We showed that the metabolite profiles of males and females are significantly different and, furthermore, that specific genetic variants in metabolism-related genes depict sexual dimorphism. Our study provides new important insights into sex-specific differences of cell regulatory processes and underscores that studies should consider sex-specific effects in design and interpretation

Flame retardant polyester by combination of organophosphorus compounds and an NOR radical forming agent

Polymer materials with different surface-to-volume ratios require different mechanisms of flame retardants regarding condensed phase and gas phase activity. The flame retardant formulations in poly(ethylene terephthalate) (PET) are investigated regarding a condensed phase and gas phase activity by using thermogravimetric analysis (TGA), TG-mass spectrometry (MS), TG-Fourier transform infrared (FTIR), UL94, cone calorimeter and scanning electron microscopy–energy-dispersive X-ray spectrometer measurements. The flame retardant formulations containing phosphates, phosphonates, and phosphinates as flame retardants are analyzed by using a simultaneous analysis consisting of a differential thermal analysis-TGA device which is in situ coupled to FTIR and MS. All analysis methods show a gas phase activity for the phosphonate (PCO 910), a condensed phase activity for the phosphate (3,9-bis(phenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro-5,5-undecane-3,9-dioxide, (SPDPP) and a mixed condensed and gas phase activity for the new synthesized phosphate and 9,10-dihydro-9-oxa-10-phosphaphenanthrene 10-oxide containing flame retardant 3,9-bis(phenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro-5,5-undecane-3,9-dioxide (SPDPDOM). The fire behavior of PCO 910 can be improved by adding O,O'-Terephthaloyl-bis-N,N'-naphthalimide ester as NOR radical-forming agent (NOR-RF) reaching a total amount of 3 wt % of both active agents for a UL94 V-0 classification in PET

Increased HRD score in cisplatin resistant penile cancer cells

Penile cancer is a rare disease in demand for new therapeutic options. Frequently used combination chemotherapy with 5 fluorouracil (5-FU) and cisplatin (CDDP) in patients with metastatic penile cancer mostly results in the development of acquired drug resistance. Availability of cell culture models with acquired resistance against standard therapy could help to understand molecular mechanisms underlying chemotherapy resistance and to identify candidate treatments for an efficient second line therapy. We generated a cell line from a humanpapilloma virus (HPV) negative penile squamous cell carcinoma (UKF-PEC-1). This cell line was subject to chronic exposure to chemotherapy with CDDP and / or 5-FU to induce acquired resistance in the newly established chemo-resistant sublines (PEC-1 CDDP , adapted to 2500 ng/ml CDDP; UKF-PEC-1 5-FU , adapted to 500 ng/ml 5- FU; UKF-PEC1 CDDP / 5-FU , adapted to 2500 ng/ml CDDP and 500 ng/ml 5 -FU). Afterwards cell line pellets were formalin-fixed, paraffin embedded and subject to sequencing as well as testing for homologous recombination deficiency (HRD). Additionally, exemplary immunohistochemical stainings for p53 and gammaH2AX were applied for verification purposes. Finally, UKF-PEC-1 CDDP , UKF-PEC-1 5-FU , UKF-PEC1 CDDP / 5-FU , and UKF-PEC-3 (an alternative penis cancer cell line) were tested for sensitivity to paclitaxel, docetaxel, olaparib, and rucaparib. The chemo-resistant sublines differed in their mutational landscapes. UKF-PEC-1 CDDP was characterized by an increased HRD score, which is supposed to be associated with increased PARP inhibitor and immune checkpoint inhibitor sensitivity in cancer. However, UKF-PEC-1 CDDP did not display sensitivity to PARP inhibitors. [Abstract copyright: © 2022. The Author(s).

Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins

Adiponutrin (PNPLA3) is a predominantly liver-expressed transmembrane protein with phospholipase activity that is regulated by fasting and feeding. Recent genome-wide association studies identified PNPLA3 to be associated with hepatic fat content and liver function, thus pointing to a possible involvement in the hepatic lipoprotein metabolism. The aim of this study was to examine the association between two common variants in the adiponutrin gene and parameters of lipoprotein metabolism in 23 274 participants from eight independent West-Eurasian study populations including six population-based studies [Bruneck (n = 800), KORA S3/F3 (n = 1644), KORA S4/F4 (n = 1814), CoLaus (n = 5435), SHIP (n = 4012), Rotterdam (n = 5967)], the SAPHIR Study as a healthy working population (n = 1738) and the Utah Obesity Case-Control Study including a group of 1037 severely obese individuals (average BMI 46 kg/m2) and 827 controls from the same geographical region of Utah. We observed a strong additive association of a common non-synonymous variant within adiponutrin (rs738409) with age-, gender-, and alanine-aminotransferase-adjusted lipoprotein concentrations: each copy of the minor allele decreased levels of total cholesterol on average by 2.43 mg/dl (P = 8.87 × 10−7), non-HDL cholesterol levels by 2.35 mg/dl (P = 2.27 × 10−6) and LDL cholesterol levels by 1.48 mg/dl (P = 7.99 × 10−4). These associations remained significant after correction for multiple testing. We did not observe clear evidence for associations with HDL cholesterol or triglyceride concentrations. In conclusion, our study suggests that adiponutrin is involved in the metabolism of apoB-containing lipoprotein

REDUCED TILLAGE AND COVER CROPS IN ORGANIC ARABLE SYSTEMS PRESERVES WEED DIVERSITY WITHOUT JEOPARDISING CROP YIELD

One of the objectives of the TILMAN-ORG Project is to improve weed management under conservation agriculture (reduced tillage and/or cover crops) in organic arable systems. The shift from ploughing to conservation agriculture should not only maintain crop yield but possibly improve weed community diversity. This paper summarises the results on (1) weed abundance, (2) weed diversity and (3) crop yield obtained in the first year of the project (2012) in 13 trials scattered across Europe